Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:364-372, doi:10.1016/S0735-1097(03)00629-6
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, K.-i.
Right arrow Articles by Imaizumi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, K.-i.
Right arrow Articles by Imaizumi, T.

Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation

Ken-ichiro Sasaki, MD*, Junli Duan, MD*, Toyoaki Murohara, MD*,{dagger},*, Hisao Ikeda, MD*, Satoshi Shintani, MD*, Toshifumi Shimada, MD*, Takako Akita, MD*, Kimiyasu Egami, MD* and Tsutomu Imaizumi, MD, FACC*

* Cardiovascular Research Institute, Kurume University School of Medicine, Kurume, Japan
{dagger} Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan



View larger version (51K):

[in a new window]
 
Figure 1 (A) Representative laser Doppler blood flow (LDBF) images at days 7, 14, and 28 are shown. (B) Before and after surgery, the hindlimb LDBF ratio did not differ among the three groups. The control group revealed progressive recovery of the ischemic/normal LDBF ratio within 28 days after induction of limb ischemia. However, the LDBF ratio was lower in the hypercholesterolemia (HC) group than in the controls. In the HC + Folate group, the LDBF ratios were significantly improved compared with the HC group; n = 6 in each group. *p < 0.05; **p < 0.01 vs. control; {dagger}p < 0.05; {dagger}{dagger}p < 0.01 vs. HC.

 


View larger version (46K):

[in a new window]
 
Figure 2 (A) Representative postmortem angiograms taken at day 14 are shown. There are numerous collateral vessels in the medial thigh area in the control group. However, the hypercholesterolemia (HC) group showed reduced collateral vessels. Folate supplementation (HC + Folate group) increased collateral vessels. (B) The angiographic score was significantly lower in the HC than in the control group, which was rescued in the HC + Folate group. n = 6 in each group; ***p < 0.001.

 


View larger version (33K):

[in a new window]
 
Figure 3 (A) The capillary density was significantly lower in the hypercholesterolemia (HC) group than in the control group in the ischemic hindlimb, which was restored in the HC + Folate group. In the nonischemic hindlimb, the capillary densities did not differ among the three groups. (B) Similarly, the capillary/muscle fiber ratio was significantly lower in the HC group than in the control group in the ischemic hindlimb, which was restored in the HC + Folate group. In the nonischemic hindlimb, the capillary/muscle fiber ratio did not differ among the three groups. n = 6 in each group; ***p < 0.001.

 


View larger version (19K):

[in a new window]
 
Figure 4 The effects of nitric oxide inhibition on angiogenesis. (A) Before and after surgery, the ischemic/normal laser Doppler blood flow (LDBF) ratio did not differ among the three groups. The reduced LDBF ratio in the hypercholesterolemia (HC) group was restored by folate administration (HC + Folate group). Treatment with N{Omega}-nitro-L-arginine methyl ester (L-NAME), the nitric oxide synthase inhibitor, markedly suppressed the recovery of LDBF ratio (HC + Folate + L-NAME group). n = 6 in each group; **p < 0.01 vs. HC + Folate; {dagger}p < 0.05; {dagger} {dagger}p < 0.01 vs. HC. (B) The angiographic score was greater in the HC + Folate group than in the HC group. The score was significantly suppressed by L-NAME treatment (HC + Folate + L-NAME group). n = 6 in each group **p < 0.01; ***p < 0.001.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement